ArticleCardiovascular diabetology2015
Normal-weight obesity is associated with increased risk of subclinical atherosclerosis.
Article in Cardiovascular diabetology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 4 syntheses or guidelines pooled it, 70 citations in OpenAlex.
- Normal Weight Central Obesity and its Impact on Type 2 Diabetes Mellitus.Current diabetes reports · 2024Pooled it
- Association of normal weight obesity phenotype with inflammatory markers: A systematic review and meta-analysis.Frontiers in immunology · 2023Pooled it
- Inflammatory Biomarkers and Components of Metabolic Syndrome in Adolescents: a Systematic Review.Inflammation · 2022Pooled it
- Normal Weight Obesity and Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis.Frontiers in endocrinology · 2022Pooled it
- Effects of high-intensity interval training on improving arterial stiffness in Chinese female university students with normal weight obese: a pilot randomized controlled trial.Journal of translational medicine · 2022Trial
- Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease incidence in metabolically healthy and unhealthy normal weight obesity.International journal of obesity (2005) · 2026Article
- Association between normal-weight central obesity and cardiometabolic disorders: a longitudinal analysis from health check-up data.BMC cardiovascular disorders · 2026Article
- Normal-Weight Obesity and an Unfavorable Cardiometabolic Profile: Results from the Study of Workers' Health (ESAT).Healthcare (Basel, Switzerland) · 2026Article
- Comparison of Abdominal Muscle and Subcutaneous Fat Thickness and Core Stability between Normal Weight Non-Obesity, Normal Weight Obesity, and Obesity Groups in Young Korean Women.Iranian journal of public health · 2025Article
- Effects of a 12-week combined exercise-nutrition intervention on body composition, physical fitness, and lifestyle disease indicators in women with normal weight obesity.Physical activity and nutrition · 2025Article
- Prevalence of normal weight obesity among adults in Southeast Asia: Insights from a systematic review and meta-analysis.Metabolism open · 2025Review
- Normal Weight Obesity Overview and Update: A narrative review.Current obesity reports · 2025Review
- Elevated body fat percentage is linked to increased risk of diabetes: a longitudinal retrospective cohort study based on Chinese adults.Frontiers in nutrition · 2025Article
- Association between normal weight obesity and comorbidities and events of cardiovascular diseases among adults in South China.PloS one · 2025Article
- Biomarkers of intestinal permeability are associated with inflammation in metabolically healthy obesity but not normal-weight obesity.American journal of physiology. Heart and circulatory physiology · 2024Article
- Weighted vest intervention during whole-body circuit training improves serum resistin, insulin resistance, and cardiometabolic risk factors in normal-weight obese women.Journal of exercise science and fitness · 2024Article
- Update on Obesity and Cardiovascular Risk: From Pathophysiology to Clinical Management.Nutrients · 2024Review
- Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management.Reviews in endocrine & metabolic disorders · 2023Review
- Associations between Normal-Weight Obesity and Disturbances in the Lipid Profile of Young Adults.Arquivos brasileiros de cardiologia · 2023Article
- Normal-Weight Obesity and Metabolic Syndrome in Korean Adults: A Population-Based Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubjects with normal body mass index (BMI) but elevated amounts of body fat (normal-weight obesity; NWO) show cardiometabolic dysregulation compared to subjects with normal BMI and normal amounts of body fat (normal-weight lean; NWL). In this study, we aimed to evaluate whether NWO individuals have higher rates of subclinical atherosclerosis compared to NWL subjects.
methodsFrom a large-scale health checkup system, we identified 2078 normal weight (18.5 ≤ BMI < 25 kg/m(2)) subjects with no previous history of coronary artery disease who underwent analysis of atherosclerosis using coronary computed tomography angiography (CCTA) and pulse wave velocity (PWV). NWO was defined as normal BMI and highest tertile of body fat percentage by sex (men ≥ 25. 4 % and women ≥ 31.4 %). CCTA was performed using a 64-detector row CT. A plaque was defined as a structure >1 mm(2) within and/or adjacent to the vessel lumen and classified according to the presence/proportion of intraplaque calcification.
resultsNWO subjects (n = 283) demonstrated metabolic dysregulation compared to NWL individuals (n = 1795). After adjusting for age, sex, and smoking, NWO individuals showed higher PWV values than NWL individuals (1474.0 ± 275.4 vs. 1380.7 ± 234.3 cm/s, p = 0.006 by ANCOVA). Compared with NWL subjects, NWO subjects had a higher prevalence of soft plaques even after age, sex, and smoking adjustment (21.6% vs. 14.5%, p = 0.039 by ANCOVA). The PWV value and the log{(number of segments with plaque) + 1} showed a positive correlation with numerous parameters such as age, systolic blood pressure, visceral fat, fasting glucose level, serum triglyceride level, and C-reactive protein (CRP) in contrast to the negative correlation with high-density lipoprotein-cholesterol level. The visceral fat was an independent determinant of log{(number of segments with plaque) + 1} (ß = 0.027, SE = 0.011, p = 0.016) even after adjustment for other significant factors. Most importantly, NWO was an independent risk factor for the presence of soft plaques (odds ratio 1.460, 95 % confidence interval 1.027-2.074, p = 0.035) even after further adjustment for multiple factors associated with atherosclerosis (blood pressure, blood glucose, lipid level, CRP, medication, smoking status, physical activity).
conclusionsNWO individuals carry a higher incidence of subclinical atherosclerosis compared with NWL individuals, regardless of other clinical risk factors for atherosclerosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.